NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
Clinical Trials
9 trialsNCT01833832 2019-07-30
Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01514526 2017-04-25
Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Spanish Oncology Genito-Urinary Group
Phase 2 Completed
NCT00831844 2015-03-30
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 2 Completed
NCT00848016 2014-05-07
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT00091182 2013-06-05
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
National Cancer Institute (NCI)
Phase 2 Completed
NCT00324012 2012-02-22
Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
Rigshospitalet, Denmark
Phase 2 Completed
NCT00001339 2008-03-04
A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00264433 2007-08-06
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
Adherex Technologies, Inc.
Phase 2 Completed